Post by piccoloking on Jan 6, 2020 11:31:34 GMT
In his last executive role, Mr. King served as Chief Executive Officer of Investment Banking at Barclays, where he presided over a restructuring of the business and spearheaded a change in strategy following global regulatory changes. During his tenure in the role, Mr. King advised on many of the largest transactions in the Consumer, Technology and Pharmaceutical sectors, including Teva Pharmaceutical’s $40.5 billion definitive agreement to acquire the Actavis generics business from Allergan.
He also managed the issue of BHP Billiton’s $6.45 billion five tranche, multicurrency subordinated bond in 2015, strengthening the bank’s Asia operations. Other transactions include the provision of $5 billion in financing to assist Kinder Morgan restructure its Master Limited Partnership; a $6 billion bridge facility to finance Williams Co.’s acquisition of a controlling stake in Access Midstream Partners and term loan facilities for British Sky Broadcasting Group.